Ann: Appendix 4C - quarterly, page-6

CEP is not a priority because DARRT and Lupin might be a more promising treatment based on current trials. Things change especially if you can get the result you are after. CEP never triggered an abscopal response. What if DARRT triggered an abscopal response?? Two out of 8 patients is already considered a very good result. My guess is DARRT did have some good results but not all of the patients did well hence the Lupin study. You dont do a Lupin phase 2 study if you dont know what is going on with the sponsored study. Remember the initial PSA response rate announced with LUPIN is really high.

CEP will be used as paliative care so still has potential. The Advisary board will recommend what to do next. We will hear from them early next year.